vs
LUXFER HOLDINGS PLC（LXFR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
LUXFER HOLDINGS PLC的季度营收约是RIGEL PHARMACEUTICALS INC的1.3倍（$90.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -3.4%，领先387.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -12.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.7%）
Luxfer Holdings PLC是一家全球性工业制造商，专注于高性能工程材料及零部件生产，核心产品包括轻量化铝制及复合材料储气系统、先进合金与特种材料，服务航空航天、医疗保健、汽车、工业制造、替代能源等全球多个核心领域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LXFR vs RIGL — 直观对比
营收规模更大
LXFR
是对方的1.3倍
$69.8M
营收增速更快
RIGL
高出33.5%
-12.3%
净利率更高
RIGL
高出387.5%
-3.4%
两年增速更快
RIGL
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.7M | $69.8M |
| 净利润 | $-3.1M | $268.1M |
| 毛利率 | 24.4% | 91.5% |
| 营业利润率 | 3.6% | 33.2% |
| 净利率 | -3.4% | 384.0% |
| 营收同比 | -12.3% | 21.2% |
| 净利润同比 | -188.6% | 1769.2% |
| 每股收益（稀释后） | $-0.12 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXFRRIGL
| Q4 25 | $90.7M | $69.8M | ||
| Q3 25 | $92.9M | $69.5M | ||
| Q2 25 | $104.0M | $101.7M | ||
| Q1 25 | $97.0M | $53.3M | ||
| Q4 24 | $103.4M | $57.6M | ||
| Q3 24 | $99.4M | $55.3M | ||
| Q2 24 | $99.7M | $36.8M | ||
| Q1 24 | $89.4M | $29.5M |
净利润LXFRRIGL
| Q4 25 | $-3.1M | $268.1M | ||
| Q3 25 | $2.7M | $27.9M | ||
| Q2 25 | $2.6M | $59.6M | ||
| Q1 25 | $5.5M | $11.4M | ||
| Q4 24 | $3.5M | $14.3M | ||
| Q3 24 | $12.7M | $12.4M | ||
| Q2 24 | $-500.0K | $-1.0M | ||
| Q1 24 | $2.7M | $-8.2M |
毛利率LXFRRIGL
| Q4 25 | 24.4% | 91.5% | ||
| Q3 25 | 23.4% | 93.2% | ||
| Q2 25 | 23.1% | 95.6% | ||
| Q1 25 | 22.1% | 91.7% | ||
| Q4 24 | 22.1% | 89.9% | ||
| Q3 24 | 22.5% | 85.5% | ||
| Q2 24 | 22.1% | 92.4% | ||
| Q1 24 | 20.6% | 93.1% |
营业利润率LXFRRIGL
| Q4 25 | 3.6% | 33.2% | ||
| Q3 25 | 5.8% | 40.9% | ||
| Q2 25 | 7.4% | 60.1% | ||
| Q1 25 | 7.8% | 23.9% | ||
| Q4 24 | 3.9% | 28.9% | ||
| Q3 24 | 17.5% | 25.4% | ||
| Q2 24 | 3.8% | 1.2% | ||
| Q1 24 | 5.5% | -23.6% |
净利率LXFRRIGL
| Q4 25 | -3.4% | 384.0% | ||
| Q3 25 | 2.9% | 40.2% | ||
| Q2 25 | 2.5% | 58.6% | ||
| Q1 25 | 5.7% | 21.5% | ||
| Q4 24 | 3.4% | 24.9% | ||
| Q3 24 | 12.8% | 22.5% | ||
| Q2 24 | -0.5% | -2.8% | ||
| Q1 24 | 3.0% | -27.9% |
每股收益（稀释后）LXFRRIGL
| Q4 25 | $-0.12 | $14.11 | ||
| Q3 25 | $0.10 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.20 | $0.63 | ||
| Q4 24 | $0.13 | $0.82 | ||
| Q3 24 | $0.47 | $0.70 | ||
| Q2 24 | $-0.02 | $-0.06 | ||
| Q1 24 | $0.10 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.3M | $155.0M |
| 总债务越低越好 | $39.4M | $52.5M |
| 股东权益账面价值 | $226.4M | $391.5M |
| 总资产 | $369.7M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LXFRRIGL
| Q4 25 | $8.3M | $155.0M | ||
| Q3 25 | $6.0M | $137.1M | ||
| Q2 25 | $4.4M | $108.4M | ||
| Q1 25 | $4.1M | $77.1M | ||
| Q4 24 | $4.1M | $77.3M | ||
| Q3 24 | $3.5M | $61.1M | ||
| Q2 24 | $4.3M | $49.1M | ||
| Q1 24 | $6.8M | $49.5M |
总债务LXFRRIGL
| Q4 25 | $39.4M | $52.5M | ||
| Q3 25 | $43.3M | $60.0M | ||
| Q2 25 | $52.6M | $60.0M | ||
| Q1 25 | $46.0M | $60.0M | ||
| Q4 24 | $45.1M | $60.0M | ||
| Q3 24 | $69.5M | $60.0M | ||
| Q2 24 | $74.2M | $60.0M | ||
| Q1 24 | $78.4M | $60.0M |
股东权益LXFRRIGL
| Q4 25 | $226.4M | $391.5M | ||
| Q3 25 | $231.6M | $117.6M | ||
| Q2 25 | $237.7M | $81.9M | ||
| Q1 25 | $226.7M | $18.6M | ||
| Q4 24 | $219.5M | $3.3M | ||
| Q3 24 | $225.1M | $-14.6M | ||
| Q2 24 | $206.3M | $-29.9M | ||
| Q1 24 | $210.3M | $-31.7M |
总资产LXFRRIGL
| Q4 25 | $369.7M | $513.6M | ||
| Q3 25 | $377.4M | $242.5M | ||
| Q2 25 | $399.2M | $206.7M | ||
| Q1 25 | $385.2M | $176.0M | ||
| Q4 24 | $382.4M | $164.0M | ||
| Q3 24 | $404.8M | $139.4M | ||
| Q2 24 | $379.8M | $128.4M | ||
| Q1 24 | $386.0M | $126.5M |
负债/权益比LXFRRIGL
| Q4 25 | 0.17× | 0.13× | ||
| Q3 25 | 0.19× | 0.51× | ||
| Q2 25 | 0.22× | 0.73× | ||
| Q1 25 | 0.20× | 3.23× | ||
| Q4 24 | 0.21× | 18.25× | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | — |
| 自由现金流率自由现金流/营收 | 13.7% | — |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $26.2M | — |
8季度趋势，按日历期对齐
经营现金流LXFRRIGL
| Q4 25 | $15.6M | $22.0M | ||
| Q3 25 | $11.8M | $24.0M | ||
| Q2 25 | $1.2M | $30.5M | ||
| Q1 25 | $5.4M | $-893.0K | ||
| Q4 24 | $25.5M | $14.5M | ||
| Q3 24 | $13.0M | $21.7M | ||
| Q2 24 | $8.9M | $302.0K | ||
| Q1 24 | $3.7M | $-5.0M |
自由现金流LXFRRIGL
| Q4 25 | $12.4M | — | ||
| Q3 25 | $10.3M | — | ||
| Q2 25 | $-700.0K | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $22.5M | — | ||
| Q3 24 | $9.8M | — | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $2.3M | — |
自由现金流率LXFRRIGL
| Q4 25 | 13.7% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | -0.7% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 21.8% | — | ||
| Q3 24 | 9.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 2.6% | — |
资本支出强度LXFRRIGL
| Q4 25 | 3.5% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率LXFRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.37× | 0.86× | ||
| Q2 25 | 0.46× | 0.51× | ||
| Q1 25 | 0.98× | -0.08× | ||
| Q4 24 | 7.29× | 1.01× | ||
| Q3 24 | 1.02× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LXFR
| Gas Cylinders Segment | $43.8M | 48% |
| Defense First Response And Healthcare | $18.6M | 21% |
| Rest Of Europe | $9.0M | 10% |
| DE | $7.0M | 8% |
| Asia Pacific | $5.8M | 6% |
| CA | $4.0M | 4% |
| Other | $2.5M | 3% |
RIGL
暂无分部数据
